{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38075843", "DateRevised": {"Year": "2023", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.3c05488"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "8", "Issue": "48", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "05"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Design, Synthesis, and Functional Studies on Noscapine and Cotarnine Amino Acid Derivatives as Antitumor Agents.", "Pagination": {"StartPage": "45502", "EndPage": "45509", "MedlinePgn": "45502-45509"}, "Abstract": {"AbstractText": ["Noscapine, a phthalide isoquinoline alkaloid isolated from the opium poppy, alongside cotarnine, a tetrahydroisoquinoline (THIQ) scaffold produced by the oxidative degradation of noscapine, has exhibited antitumor activities against several types of cancer. Although derivatization with amino acids is regarded as a promising strategy to improve chemotherapeutics' anticancer properties, amino acid conjugates of noscapine and cotarnine have been the least investigated. In the present study, 20 amino acid conjugated derivatives of noscapine and cotarnine at the 6-position were synthesized and evaluated for anticancer activity in both in vitro and in vivo conditions. Analysis of the antiproliferative activity against 4T1 mammary carcinoma tumor cells showed that compounds <b>6h</b> (noscapine-phenylalanine), <b>6i</b> (noscapine-tryptophan), and <b>10i</b> (cotarnine-tryptophan) with IC<sub>50</sub> values of 11.2, 16.3, and 54.5 \u03bcM, respectively, were found to be far more potent than noscapine (IC<sub>50</sub> = 215.5 \u03bcM) and cotarnine (IC<sub>50</sub> = 575.3 \u03bcM) and were consequently opted for further characterization. Annexin V and propidium iodide staining followed by flow cytometry demonstrated improved apoptotic activity of compounds <b>6h</b>, <b>6i</b>, and <b>10i</b> compared to those of noscapine and cotarnine. In a murine model of 4T1 mammary carcinoma, noscapine-tryptophan inhibited tumor growth more effectively than noscapine and the other amino acid conjugates without adverse effects. Moreover, molecular docking studies conducted on tubulin as the intracellular target of noscapine suggested a good correlation with experimental observations. Based on these results, noscapine-tryptophan could be a promising candidate for further preclinical investigations."], "CopyrightInformation": "\u00a9 2023 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113, Tehran, Iran."}], "LastName": "Davarzani", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": ["0000-0001-5774-3372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113, Tehran, Iran."}], "LastName": "Salehi", "ForeName": "Peyman", "Initials": "P"}, {"Identifier": ["0000-0002-0782-6687"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 13145-1384, Iran."}], "LastName": "Asghari", "ForeName": "S Mohsen", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113, Tehran, Iran."}], "LastName": "Bararjanian", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 13145-1384, Iran."}], "LastName": "Hamrahi Mohsen", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113, Tehran, Iran."}], "LastName": "Dehghan Harati", "ForeName": "Helia", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kashyap D.; Tuli H. S.; Yerer M. B.; Sharma A.; Sak K.; Srivastava S.; Pandey A.; Garg V. K.; Sethi G.; Bishayee A. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin. Cancer Biol. 2021, 69, 5\u201323. 10.1016/j.semcancer.2019.08.014.", "ArticleIdList": ["10.1016/j.semcancer.2019.08.014", "31421264"]}, {"Citation": "Pingaew R.; Mandi P.; Nantasenamat C.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity. Eur. J. Med. Chem. 2014, 81, 192\u2013203. 10.1016/j.ejmech.2014.05.019.", "ArticleIdList": ["10.1016/j.ejmech.2014.05.019", "24836071"]}, {"Citation": "Khan A. Y.; Suresh Kumar G. Natural isoquinoline alkaloids: binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme. Biophys. Rev. 2015, 7, 407\u2013420. 10.1007/s12551-015-0183-5.", "ArticleIdList": ["10.1007/s12551-015-0183-5", "PMC5418488", "28510102"]}, {"Citation": "Ramanivas T.; Sushma B.; Nayak V. L.; Chandra Shekar K.; Srivastava A. K. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents. Eur. J. Med. Chem. 2015, 92, 608\u2013618. 10.1016/j.ejmech.2015.01.030.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.030", "25615796"]}, {"Citation": "Singh I. P.; Shah P. Tetrahydroisoquinolines in therapeutics: a patent review (2010\u20132015). Expert Opin. Ther. Pat. 2017, 27, 17\u201336. 10.1080/13543776.2017.1236084.", "ArticleIdList": ["10.1080/13543776.2017.1236084", "27623022"]}, {"Citation": "Tomar R.; Sahni A.; Chandra I.; Tomar V.; Chandra R. Review of Noscapine and its Analogues as Potential Anti-Cancer Drugs. Mini-Reviews Org. Chem. 2018, 15, 345\u2013363. 10.2174/1570193X15666180221153911.", "ArticleIdList": ["10.2174/1570193X15666180221153911"]}, {"Citation": "DeBono A. J.; Mistry S. J.; Xie J.; Muthiah D.; Phillips J.; Ventura S.; Callaghan R.; Pouton C. W.; Capuano B.; Scammells P. J. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents. ChemMedChem 2014, 9, 399\u2013410. 10.1002/cmdc.201300395.", "ArticleIdList": ["10.1002/cmdc.201300395", "24339417"]}, {"Citation": "Bennani Y. L.; Gu W.; Canales A.; D\u00edaz F. J.; Eustace B. K.; Hoover R. R.; Jim\u00e9nez-Barbero J.; Nezami A.; Wang T. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives. J. Med. Chem. 2012, 55, 1920\u20131925. 10.1021/jm200848t.", "ArticleIdList": ["10.1021/jm200848t", "22320354"]}, {"Citation": "Ye K.; Ke Y.; Keshava N.; Shanks J.; Kapp J. A.; Tekmal R. R.; Petros J.; Joshi H. C. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 1601\u20131606. 10.1073/pnas.95.4.1601.", "ArticleIdList": ["10.1073/pnas.95.4.1601", "PMC19111", "9465062"]}, {"Citation": "Checchi P. M.; Nettles J. H.; Zhou J.; Snyder J. P.; Joshi H. C. Microtubule-interacting drugs for cancer treatment. Trends Pharmacol. Sci. 2003, 24, 361\u2013365. 10.1016/s0165-6147(03)00161-5.", "ArticleIdList": ["10.1016/s0165-6147(03)00161-5", "12871669"]}, {"Citation": "Capilla A. S.; Soucek R.; Grau L.; Romero M.; Rubio-Mart\u00ednez J.; Caignard D. H.; Pujol M. D. Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties. Eur. J. Med. Chem. 2018, 145, 51\u201363. 10.1016/j.ejmech.2017.12.098.", "ArticleIdList": ["10.1016/j.ejmech.2017.12.098", "29324343"]}, {"Citation": "Bentley K. W.; Berberines O. M.; Alkaloids R.; Alkaloids A.; Aporphines D.; Dimers A.-B.; Acids A.; Alkaloids M.; Alkaloids H.; Alkaloids O. \u03b2-Phenylethylamines and the isoquinoline alkaloids. Nat. Prod. Rep. 1989, 6, 405\u2013432. 10.1039/NP9890600405.", "ArticleIdList": ["10.1039/NP9890600405", "2674787"]}, {"Citation": "Choudhury S. K.; Rout P.; Parida B. B.; Florent J. C.; Johannes L.; Phaomei G.; Bertounesque E.; Rout L. Metal-Free Activation of C (sp3)-H Bond, and a Practical and Rapid Synthesis of Privileged 1-Substituted 1, 2, 3, 4-Tetrahydroisoquinolines. Eur. J. Org Chem. 2017, 2017, 5275\u20135292. 10.1002/ejoc.201700471.", "ArticleIdList": ["10.1002/ejoc.201700471"]}, {"Citation": "Sahu S. K.; Behera P. K.; Panda S.; Choudhury P.; Rout L. Developments in chemistry and biological application of cotarnine & its analogs. Tetrahedron 2020, 76, 131663.10.1016/j.tet.2020.131663.", "ArticleIdList": ["10.1016/j.tet.2020.131663"]}, {"Citation": "Devine S. M.; Yong C.; Amenuvegbe D.; Aurelio L.; Muthiah D.; Pouton C.; Callaghan R.; Capuano B.; Scammells P. J. Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents. J. Med. Chem. 2018, 61, 8444\u20138456. 10.1021/acs.jmedchem.8b00986.", "ArticleIdList": ["10.1021/acs.jmedchem.8b00986", "30156410"]}, {"Citation": "Blaskovich M. A. T. Unusual Amino Acids in Medicinal Chemistry. J. Med. Chem. 2016, 59, 10807\u201310836. 10.1021/acs.jmedchem.6b00319.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00319", "27589349"]}, {"Citation": "Han J.; Konno H.; Sato T.; Soloshonok V. A.; Izawa K. Tailor-made amino acids in the design of small-molecule blockbuster drugs. Eur. J. Med. Chem. 2021, 220, 113448.10.1016/j.ejmech.2021.113448.", "ArticleIdList": ["10.1016/j.ejmech.2021.113448", "33906050"]}, {"Citation": "Csuk R.; Schwarz S.; Siewert B.; Kluge R.; Str\u00f6hl D. Synthesis and cytotoxic activity of methyl glycyrrhetinate esterified with amino acids. Z. Naturforsch., B: Chem. Sci. 2012, 67, 731\u2013746. 10.5560/znb.2012-0107.", "ArticleIdList": ["10.5560/znb.2012-0107"]}, {"Citation": "Fang L.; Wang M.; Gou S.; Liu X.; Zhang H.; Cao F. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs. J. Med. Chem. 2014, 57, 1116\u20131120. 10.1021/jm401634d.", "ArticleIdList": ["10.1021/jm401634d", "24422538"]}, {"Citation": "Guo W. B.; Zhang H.; Yan W. Q.; Liu Y. M.; Zhou F.; Cai D. S.; Zhang W. X.; Huang X. M.; Jia X. H.; Chen H. S.; Qi J. C.; Wang P. L.; Xu B.; Lei H. M. Design, synthesis, and biological evaluation of ligustrazine - betulin amino-acid/dipeptide derivatives as anti-tumor agents. Eur. J. Med. Chem. 2020, 185, 111839.10.1016/j.ejmech.2019.111839.", "ArticleIdList": ["10.1016/j.ejmech.2019.111839", "31708185"]}, {"Citation": "DeBono A.; Capuano B.; Scammells P. J. Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents. J. Med. Chem. 2015, 58, 5699\u20135727. 10.1021/jm501180v.", "ArticleIdList": ["10.1021/jm501180v", "25811651"]}, {"Citation": "Awasthi A.; Kumar N.; Mishra A.; Ravi R.; Dalal A.; Shankar S.; Chandra R. Noscapine-Amino Acid Conjugates Suppress the Progression of Cancer Cells. ACS Pharmacol. Transl. Sci. 2022, 5, 1292\u20131304. 10.1021/acsptsci.2c00172.", "ArticleIdList": ["10.1021/acsptsci.2c00172", "PMC9745893", "36524011"]}, {"Citation": "Nemati F.; Bischoff-Kont I.; Salehi P.; Nejad-Ebrahimi S.; Mohebbi M.; Bararjanian M.; Hadian N.; Hassanpour Z.; Jung Y.; Schaerlaekens S.; Lucena-Agell D.; Oliva M. A.; F\u00fcrst R.; Nasiri H. R. Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library. Bioorg. Chem. 2021, 115, 105135.10.1016/j.bioorg.2021.105135.", "ArticleIdList": ["10.1016/j.bioorg.2021.105135", "34303039"]}, {"Citation": "Debono A. J.; Xie J. H.; Ventura S.; Pouton C. W.; Capuano B.; Scammells P. J. Synthesis and Biological Evaluation of N-Substituted Noscapine Analogues. ChemMedChem 2012, 7, 2122\u20132133. 10.1002/cmdc.201200365.", "ArticleIdList": ["10.1002/cmdc.201200365", "23055449"]}, {"Citation": "Nemati F.; Salehi P.; Bararjanian M.; Hadian N.; Mohebbi M.; Lauro G.; Ruggiero D.; Terracciano S.; Bifulco G.; Bruno I. Discovery of noscapine derivatives as potential \u03b2-tubulin inhibitors. Bioorg. Med. Chem. Lett. 2020, 30, 127489.10.1016/j.bmcl.2020.127489.", "ArticleIdList": ["10.1016/j.bmcl.2020.127489", "32784088"]}, {"Citation": "Cheriyamundath S.; Mahaddalkar T.; Reddy Nagireddy P. K.; Sridhar B.; Kantevari S.; Lopus M. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine. Pharmacol. Rep. 2019, 71, 48\u201353. 10.1016/j.pharep.2018.09.002.", "ArticleIdList": ["10.1016/j.pharep.2018.09.002", "30465924"]}, {"Citation": "Zimmermann T. J.; Roy S.; Martinez N. E.; Ziegler S.; Hedberg C.; Waldmann H. Biology-Oriented Synthesis of a Tetrahydroisoquinoline-Based Compound Collection Targeting Microtubule Polymerization. ChemBioChem 2013, 14, 295\u2013300. 10.1002/cbic.201200711.", "ArticleIdList": ["10.1002/cbic.201200711", "23364933"]}, {"Citation": "Pragyandipta P.; Naik M. R.; Bastia B.; Naik P. K. Development of 9-(N-arylmethylamino) congeners of noscapine: the microtubule targeting drugs for the management of breast cancer. 3 Biotech 2023, 13, 38.10.1007/s13205-022-03445-3.", "ArticleIdList": ["10.1007/s13205-022-03445-3", "PMC9829942", "36636578"]}, {"Citation": "Nagireddy P. K. R.; Kumar D.; Kommalapati V. K.; Pedapati R. K.; Kojja V.; Tangutur A. D.; Kantevari S. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer. Drug Dev. Res. 2021, 83, 605\u2013614. 10.1002/ddr.21888.", "ArticleIdList": ["10.1002/ddr.21888", "34612529"]}, {"Citation": "Yang Z. R.; Liu M.; Peng X. L.; Lei X. F.; Zhang J. X.; Dong W. G. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem. Biophys. Res. Commun. 2012, 421, 627\u2013633. 10.1016/j.bbrc.2012.04.079.", "ArticleIdList": ["10.1016/j.bbrc.2012.04.079", "22546556"]}, {"Citation": "Aneja R.; Zhou J.; Vangapandu S. N.; Zhou B.; Chandra R.; Joshi H. C. Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011. Blood 2006, 107, 2486.10.1182/blood-2005-08-3516.", "ArticleIdList": ["10.1182/blood-2005-08-3516", "PMC1895738", "16282340"]}, {"Citation": "Liu M.; Luo X. J.; Liao F.; Lei X. F.; Dong W. G. Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol. 2011, 67, 605\u2013612. 10.1007/s00280-010-1356-3.", "ArticleIdList": ["10.1007/s00280-010-1356-3", "20490799"]}, {"Citation": "Xu G.; Niu Z.; Dong J.; Zhao Y.; Zhang Y.; Li X. Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo. Neoplasma 2016, 63, 726\u2013733. 10.4149/neo_2016_509.", "ArticleIdList": ["10.4149/neo_2016_509", "27468876"]}, {"Citation": "Morris G. M.; Goodsell D. S.; Halliday R. S.; Huey R.; Hart W. E.; Belew R. K.; Olson A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639\u20131662. 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.", "ArticleIdList": ["10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"]}, {"Citation": "Ravelli R. B. G.; Gigant B.; Curmi P. A.; Jourdain I.; Lachkar S.; Sobel A.; Knossow M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004, 428, 198\u2013202. 10.1038/nature02393.", "ArticleIdList": ["10.1038/nature02393", "15014504"]}, {"Citation": "Kumar S.; Jaipuri F. A.; Waldo J. P.; Potturi H.; Marcinowicz A.; Adams J.; Van Allen C.; Zhuang H.; Vahanian N.; Link C.; Brincks E. L.; Mautino M. R. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur. J. Med. Chem. 2020, 198, 112373.10.1016/j.ejmech.2020.112373.", "ArticleIdList": ["10.1016/j.ejmech.2020.112373", "32422549"]}, {"Citation": "Babanezhad Harikandei K.; Salehi P.; Ebrahimi S. N.; Bararjanian M.; Kaiser M.; Khavasi H. R.; Al-Harrasi A. N-substituted noscapine derivatives as new antiprotozoal agents: Synthesis, antiparasitic activity and molecular docking study. Bioorg. Chem. 2019, 91, 103116.10.1016/j.bioorg.2019.103116.", "ArticleIdList": ["10.1016/j.bioorg.2019.103116", "31377384"]}, {"Citation": "Rout L. Synthesis of Acyl Derivatives of Cotarnine. Org. Synth. 2018, 95, 455\u2013471. 10.15227/orgsyn.095.0455.", "ArticleIdList": ["10.15227/orgsyn.095.0455"]}, {"Citation": "Zhao D.; Mao Y.; Song S.; Cheng M. A New Total Synthesis of (\u00b1)-\u03b1-Noscapine. Heterocycles 2013, 87, 2633\u20132640. 10.3987/COM-13-12843.", "ArticleIdList": ["10.3987/COM-13-12843"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "27"}, {"Year": "2023", "Month": "10", "Day": "8"}, {"Year": "2023", "Month": "11", "Day": "10"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "11", "Hour": "6", "Minute": "2"}, {"Year": "2023", "Month": "11", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["38075843", "PMC10702327", "10.1021/acsomega.3c05488"]}}], "PubmedBookArticle": []}